Winner Medical Co., Ltd. (SHE:300888)

Winner Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,532	1,412	4,706	4,527	4,274	4,163
Short-Term Investments	346.06	340.99	-	101.67	50.16	-
Trading Asset Securities	2,125	2,921	2,850	4,379	3,131	4,131
Cash & Short-Term Investments	4,003	4,674	7,556	9,007	7,455	8,294
Cash Growth	-37.86%	-38.14%	-16.11%	20.83%	-10.12%	1624.84%
Accounts Receivable	1,277	1,088	845.29	1,077	785.49	862.5
Other Receivables	178.49	186.35	218.91	236.3	329.18	458.17
Receivables	1,456	1,274	1,064	1,313	1,115	1,321
Inventory	1,946	1,958	1,434	1,559	1,597	1,216
Other Current Assets	238.93	174.79	501.14	246.61	179.06	159.22
Total Current Assets	7,644	8,081	10,556	12,126	10,346	10,990
Property, Plant & Equipment	5,134	5,024	4,151	3,550	2,225	1,462
Long-Term Investments	2,398	553.26	90.88	61.75	16.95	13.42
Goodwill	1,249	1,251	864.29	1,045	-	-
Other Intangible Assets	1,050	1,096	995.23	1,033	265.7	208.33
Long-Term Accounts Receivable	32.05	31.21	35.69	-	-	-
Long-Term Deferred Tax Assets	132.17	139	175.35	211.97	122.72	143.13
Long-Term Deferred Charges	123.76	143.86	131.09	132.69	174.79	121.34
Other Long-Term Assets	254.75	2,072	112.55	92.27	115.57	63.81
Total Assets	18,018	18,392	17,112	18,253	13,267	13,002
Accounts Payable	1,308	1,588	1,433	1,144	770.72	756
Accrued Expenses	502.47	525.58	530.34	714.42	448.46	264.91
Short-Term Debt	1,812	1,969	1,493	2,295	-	150.07
Current Portion of Long-Term Debt	-	181.13	20.14	8.01	-	-
Current Portion of Leases	205.9	215.05	202.66	207.31	216.18	-
Current Income Taxes Payable	66.22	82.32	40.19	197.57	80.63	415.53
Current Unearned Revenue	168.11	182.76	193.26	566.82	341.18	684.5
Other Current Liabilities	477.6	527.9	358.47	353.78	217.57	155.77
Total Current Liabilities	4,540	5,272	4,271	5,487	2,075	2,427
Long-Term Debt	76.48	101.54	170	-	-	-
Long-Term Leases	412.91	440.88	292.01	326.46	381.81	-
Long-Term Unearned Revenue	177.95	157.15	121.65	98.79	109.63	94.92
Long-Term Deferred Tax Liabilities	146.88	158.52	138.52	133.68	13.34	12.17
Other Long-Term Liabilities	378.23	377.48	-	-	-	-
Total Liabilities	5,742	6,516	5,002	6,055	2,580	2,534
Common Stock	582.33	582.33	594.39	426.49	426.49	426.49
Additional Paid-In Capital	3,406	3,379	4,381	4,546	4,550	4,482
Retained Earnings	7,547	7,200	7,029	7,246	5,958	5,547
Treasury Stock	-7.19	-7.28	-473.55	-500.08	-257.99	-
Comprehensive Income & Other	-4.76	-2.64	2.22	0.78	-1.56	-1.11
Total Common Equity	11,523	11,151	11,533	11,720	10,675	10,454
Minority Interest	752.95	724.39	577.1	478.16	12.2	14.46
Shareholders' Equity	12,276	11,876	12,110	12,198	10,687	10,468
Total Liabilities & Equity	18,018	18,392	17,112	18,253	13,267	13,002
Total Debt	2,507	2,908	2,178	2,837	597.99	150.07
Net Cash (Debt)	1,496	1,767	5,378	6,170	6,857	8,144
Net Cash Growth	-67.44%	-67.15%	-12.84%	-10.01%	-15.80%	3574.47%
Net Cash Per Share	2.57	3.02	9.08	10.43	11.50	14.95
Filing Date Shares Outstanding	586.57	582.33	583.94	587.63	587.63	597.09
Total Common Shares Outstanding	586.57	582.33	588.14	587.63	587.63	597.09
Working Capital	3,104	2,810	6,285	6,638	8,271	8,563
Book Value Per Share	19.64	19.15	19.61	19.94	18.17	17.51
Tangible Book Value	9,224	8,804	9,674	9,642	10,409	10,246
Tangible Book Value Per Share	15.73	15.12	16.45	16.41	17.71	17.16
Land	2.69	2.69	-	-	-	-
Buildings	2,977	2,406	1,967	1,496	949.42	878.49
Machinery	2,532	2,389	1,983	1,863	1,238	1,119
Construction In Progress	599.32	1,075	984.57	765.01	216.1	61.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.